000 | 01071 a2200313 4500 | ||
---|---|---|---|
005 | 20250514222502.0 | ||
264 | 0 | _c20050728 | |
008 | 200507s 0 0 eng d | ||
022 | _a0300-5127 | ||
024 | 7 |
_a10.1042/BST0330371 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeighton, B | |
245 | 0 | 0 |
_aSmall molecule glucokinase activators as novel anti-diabetic agents. _h[electronic resource] |
260 |
_bBiochemical Society transactions _cApr 2005 |
||
300 |
_a371-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDiabetes Mellitus _xblood |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aGlucokinase _xmetabolism |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aInsulin _xmetabolism |
700 | 1 | _aAtkinson, A | |
700 | 1 | _aCoghlan, M P | |
773 | 0 |
_tBiochemical Society transactions _gvol. 33 _gno. Pt 2 _gp. 371-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1042/BST0330371 _zAvailable from publisher's website |
999 |
_c15458691 _d15458691 |